Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC209

Pibrentasvír eða lyfjafræðilega viðunandi salt þar af

  • Status:
    Veitt
  • Application date:
    15.11.2017
  • Application published:
    15.12.2017
  • Grant published:
    15.8.2018
  • Max expiry date:
    27.1.2033
  • Medicine name:
    Maviret
  • Medicine for children:
    Yes

Timeline

Today
15.11.2017Application
15.12.2017Publication
15.8.2018Registration
27.1.2033Expires

Marketing license

  • IS authorization number:
    EU/1/17/1213/001
  • Date:
    17.8.2017
  • Foreign authorization number:
    EU/1/17/1213
  • Date:
    26.7.2017

Owner

  • Name:
    AbbVie Manufacturing Management Unlimited Company
  • Address:
    70 Sir John Rogerson's Quay, Dublin 2 IE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 12.05.2022

Upload documents